UF researchers score gene therapy advance: Animal study shows high blood pressure prevented in future generations

GAINESVILLE---A form of gene therapy to ward off high blood pressure in rats appears to permanently alter the animals' DNA blueprint, preventing their offspring from inheriting the disorder, University of Florida scientists report today (11/12) in Circulation Research: Journal of the American Heart Association.

The advance represents the first time researchers have been able to protect future generations through gene therapy for any condition, said UF molecular physiologist Mohan K. Raizada. Other studies have shown random bits of inserted genes can be passed on, but with no therapeutic effect. The new approach involves using a form of genetic brilliance to block the action of a harmful hormone, angiotensin, which causes blood vessels to narrow, increasing blood pressure.

"The neat part of this study is we're able to show both the effects on high blood pressure as well as on the organs involved in the control of blood pressure," Raizada said. "We have shown that this form of gene therapy not only prevents these animals from developing high blood pressure but also prevents a lot of other types of pathophysiological changes in the heart, the kidney and the arteries."

What's more, after studying two subsequent generations of rats - the original animals' "children" and "grandchildren" - researchers discovered the beneficial changes were passed on. Those offspring should have had high blood pressure but didn't, said UF vascular biologist

Craig H. Gelband. Raizada and Gelband, who are affiliated with UF's College of Medicine and the campuswide Genetics Institute, collaborated with Michael J. Katovich, in the university's College of Pharmacy on the study. The project was funded by the National Institutes of Health and the

American Heart Association's Florida affiliate. Findings from related research also were presented at this week's annual meeting of the American Heart Association in Atlanta.

While it may be years before the approach is teste

Contact: Melanie Fridl Ross
University of Florida

Page: 1 2 3

Related biology news :

1. Belgian researchers explore revolutionary approach to angiogenesis
2. Award winning researchers reveal potential new role for Glivec
3. $7.5 Million grant to Yale researchers for role of viruses in cancer
4. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
5. Joslin researchers clarify mechanisms for beta-cell formation
6. Virginia Tech researchers to release findings on Smith River Project
7. Molecular motor myosin VI moves hand over hand, researchers say
8. ASU researchers demonstrate new technique that improves the power of atomic force micrscopy
9. Emory researchers map structure of anti-cancer molecule
10. Leukemia stem cells identified by Stanford researchers
11. EURYI Award given for the first time to 25 young European researchers

Post Your Comments:

(Date:8/26/2020)... ... August 25, 2020 , ... ... solutions for drugs, biologics, cell and gene therapies, and consumer health products, today ... PEGS Boston Virtual Conference & Expo, taking place between Aug. 31 – September ...
(Date:8/21/2020)... ... August 19, 2020 , ... “How can we ... dedicated to Salivary Bioscience for more than twenty years. Together with Douglas Granger, ... " Salivary Bioscience: Foundations of Interdisciplinary Saliva Research and Applications ," and Steven ...
(Date:8/12/2020)... , ... August 12, 2020 , ... ... monitoring systems that are ideal for public health agencies of all sizes. With ... diseases and helping at-risk individuals find appropriate health care, Mosio helps public health ...
Breaking Biology News(10 mins):
(Date:8/31/2020)... , ... August 29, 2020 , ... ... Animal Nutrition manufacturing capability in Wuxi, China. The new plant operation will provide ... standards and advanced technology. , “This facility will improve the flexibility of ...
(Date:8/12/2020)... ... August 11, 2020 , ... The FSHD ... Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network (FSHD CTRN), with consideration ... is a consortium of academic research centers in the United States and Europe ...
(Date:8/7/2020)... Texas (PRWEB) , ... August 06, 2020 , ... ... and DNA vaccine industries, announces it has closed on the purchase of greenfield ... Park in Conroe, TX and includes over 21 acres in the initial acquisition, ...
(Date:7/31/2020)... Ariz. (PRWEB) , ... July 29, 2020 , ... R3 ... joint injections for only $3950. With 50 million stem cells total, patients may choose ... stem cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, ...
Breaking Biology Technology:
Cached News: